» Articles » PMID: 17873065

Orphan Nuclear Receptor TLX Recruits Histone Deacetylases to Repress Transcription and Regulate Neural Stem Cell Proliferation

Overview
Specialty Science
Date 2007 Sep 18
PMID 17873065
Citations 130
Authors
Affiliations
Soon will be listed here.
Abstract

TLX is a transcription factor that is essential for neural stem cell proliferation and self-renewal. However, the molecular mechanism of TLX-mediated neural stem cell proliferation and self-renewal is largely unknown. We show here that TLX recruits histone deacetylases (HDACs) to its downstream target genes to repress their transcription, which in turn regulates neural stem cell proliferation. TLX interacts with HDAC3 and HDAC5 in neural stem cells. The HDAC5-interaction domain was mapped to TLX residues 359-385, which contains a conserved nuclear receptor-coregulator interaction motif IXXLL. Both HDAC3 and HDAC5 have been shown to be recruited to the promoters of TLX target genes along with TLX in neural stem cells. Recruitment of HDACs led to transcriptional repression of TLX target genes, the cyclin-dependent kinase inhibitor, p21(CIP1/WAF1)(p21), and the tumor suppressor gene, pten. Either inhibition of HDAC activity or knockdown of HDAC expression led to marked induction of p21 and pten gene expression and dramatically reduced neural stem cell proliferation, suggesting that the TLX-interacting HDACs play an important role in neural stem cell proliferation. Moreover, expression of a TLX peptide containing the minimal HDAC5 interaction domain disrupted the TLX-HDAC5 interaction. Disruption of this interaction led to significant induction of p21 and pten gene expression and to dramatic inhibition of neural stem cell proliferation. Taken together, these findings demonstrate a mechanism for neural stem cell proliferation through transcriptional repression of p21 and pten gene expression by TLX-HDAC interactions.

Citing Articles

Nuclear receptor TLX functions to promote cancer stemness and EMT in prostate cancer via its direct transactivation of CD44 and stem cell-regulatory transcription factors.

Chow S, Fan J, Zhang X, Wang Y, Li Y, Ng C Br J Cancer. 2024; 131(9):1450-1462.

PMID: 39322688 PMC: 11519473. DOI: 10.1038/s41416-024-02843-z.


Manifestations of COVID-19 in the posterior eye segment - Up-to-date.

Marzoog B Oman J Ophthalmol. 2024; 17(2):166-172.

PMID: 39132129 PMC: 11309540. DOI: 10.4103/ojo.ojo_212_22.


Epigenetic regulation in adult neural stem cells.

Shi J, Wang Z, Wang Z, Shao G, Li X Front Cell Dev Biol. 2024; 12:1331074.

PMID: 38357000 PMC: 10864612. DOI: 10.3389/fcell.2024.1331074.


The differential response to neuronal hyperexcitation and neuroinflammation of the hippocampal neurogenic niche.

Ruiz-Clavijo L, Martin-Suarez S Front Neurosci. 2023; 17:1186256.

PMID: 37496737 PMC: 10366379. DOI: 10.3389/fnins.2023.1186256.


Apigenin inhibits angiogenesis in retinal microvascular endothelial cells through regulating of the miR-140-5p/HDAC3-mediated PTEN/PI3K/AKT pathway.

Fu C, Peng J, Ling Y, Zhao H, Zhao Y, Zhang X BMC Ophthalmol. 2023; 23(1):302.

PMID: 37415101 PMC: 10326941. DOI: 10.1186/s12886-023-03046-5.


References
1.
Perissi V, Rosenfeld M . Controlling nuclear receptors: the circular logic of cofactor cycles. Nat Rev Mol Cell Biol. 2005; 6(7):542-54. DOI: 10.1038/nrm1680. View

2.
McKenna N, Lanz R, OMalley B . Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev. 1999; 20(3):321-44. DOI: 10.1210/edrv.20.3.0366. View

3.
Wang L, Rajan H, Pitman J, McKeown M, Tsai C . Histone deacetylase-associating Atrophin proteins are nuclear receptor corepressors. Genes Dev. 2006; 20(5):525-30. PMC: 1410805. DOI: 10.1101/gad.1393506. View

4.
Zhang C, Zou Y, Yu R, Gage F, Evans R . Nuclear receptor TLX prevents retinal dystrophy and recruits the corepressor atrophin1. Genes Dev. 2006; 20(10):1308-20. PMC: 1472905. DOI: 10.1101/gad.1413606. View

5.
Nagy L, Kao H, Love J, Li C, Banayo E, Gooch J . Mechanism of corepressor binding and release from nuclear hormone receptors. Genes Dev. 2000; 13(24):3209-16. PMC: 317208. DOI: 10.1101/gad.13.24.3209. View